Luigi Di Biase

https://assets.montefioreeinstein.org/profiles/images/physphoto/DiBiase_Luigi_MD_PhD_420x504.jpg

First Name

Luigi

Last Name

Di Biase

NPI

1891045837

Faculty ID

13629

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<blockquote>
<p class="lessPadding">Dr. Luigi Di Biase is Section Head of Electrophysiology, Director of Arrhythmia Services, and Professor of Medicine (Cardiology) at Einstein/Montefiore. In addition, he serves as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, Texas.</p>
<p>Improving patient care is the heart of Dr. Di Biase's mission. He believes that this is possible through dedicated clinical practice associated to cutting-edge clinical research. Dr. Di Biase's research focuses on cardiology and electrophysiology with specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices.</p>
<p>Dr. Di Biase, MD, PhD, FACC, FHRS, is a 2000 graduate (summa cum laude) of the medical school and a 2004 graduate (summa cum laude) of the cardiology residency program at the University of Bari, Bari, Italy. In 2006, he completed a second-level master degree in Electrophysiology and Pacing (summa cum laude) at the University of Insubria, Varese, Italy.</p>
<p>In 2007, Dr. Di Biase received a grant from the Italian National Society of Cardiology to pursue a research fellowship under the supervision of Dr. Andrea Natale at the Miller Family Heart &amp; Vascular Institute at the Cleveland Clinic, Cleveland, Ohio. The following year, he accepted a position in cardiac electrophysiology at the University of Texas Medical School Branch in Galveston, Texas, where he continued to focus on his research projects at St. David's Medical Center under the leadership of Dr. Natale.</p>
<p>Dr. Di Biase was appointed Assistant Professor in 2007 at the University of Foggia, Italy, where he completed the PhD program in cardiovascular physiopathology in November 2010.</p>
<p>In 2009, Dr. Di Biase was appointed Adjunct Assistant Professor at the University of Texas at Austin, where he was promoted to Adjunct Associate Professor in 2012, the same year he joined Albert Einstein College of Medicine and Montefiore Medical Center&nbsp;with the title of Associate Professor, Department of Medicine (Cardiology).</p>
<p>In September 2014 Dr. Di Biase was appointed Section Head of Electrophysiology and Director of Arrhythmia Services at Einstein/Montefiore, while continuing to serve as Senior Researcher at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center.&nbsp;</p>
<p>Subsequently Dr. Di Biase was promoted to the rank of Professor of Medicine, Department of Medicine (Cardiology).</p>
<p>Dr. Di Biase is the author of more than 450 publications in indexed journals, about 500 abstracts, and 18 electrophysiology book chapters. He has presented at numerous national and international conferences as an invited speaker.</p>
<p class="lessPadding">Dr. Di Biase is a member of the Italian Federation of Cardiology and Electrophysiology (FIC-AIAC), the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA), the American College of Cardiology (ACC), the American Heart Association (AHA), and a Fellow of the Heart Rhythm Society (FHRS), and the American College of Cardiology (FACC). He is also an honorary member of the Korean Society of Cardiology.</p>
<p class="lessPadding">Dr Di Biase serves as reviewer of major electrophysiology and cardiology journals, and as an editorial board member of&nbsp;<em>Heart Rhythm Journal</em>,&nbsp;<em>Heart Rhythm Journal Case Report</em>, and&nbsp;<em>Journal of Cardiovascular Medicine</em>. He is Associate Editor for&nbsp;<em>Journal Interventional Cardiac Electrophysiology (JICE)</em>&nbsp;and Associate Section Editor for&nbsp;<em>Pacing and Clinical Electrophysiology (PACE)</em>.</p>
<p class="lessPadding">Dr. Di Biase sees patients on both Einstein and Moses campuses of Montefiore Medical Center and at the Hutch Metro Center at Water Place.</p>
<p class="lessPadding"><strong><br /></strong></p>
<p class="lessPadding"><strong>More Information About Dr. Luigi Di Biase</strong></p>
<p class="lessPadding"><a href="http://www.einstein.yu.edu/departments/medicine/divisions/cardiology/ne… is More in Ablation for Ventricular Arrhythmia</a></p>
<p><a href="http://www.einstein.yu.edu/departments/medicine/divisions/cardiology/ne…; target="blank">Can the shape of the left atrial appendage affect stroke risk?</a></p>
<p><a href="http://www.einstein.yu.edu/departments/medicine/divisions/cardiology/ne…; target="blank">Continuous Warfarin Therapy for Patients Undergoing Catheter Ablation</a></p>
</blockquote>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Improving patient care is the heart of Dr. Di Biase's mission. He believes this is possible through dedicated clinical practice associated to cutting-edge clinical research.</p>

Research Focus

<p>Dr. Di Biase's research focuses on cardiology and electrophysiology with specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices.</p>

Elsevier Profile

Selected Publications

<ol>
<li>Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, Gallinghouse GJ, Bailey SM, Zagrodzky JD, Santangeli P, Hao S, Hongo R, Beheiry S, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Al-Ahmad A, Wang P, Cummings JE, Schweikert RA, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Lewis WR, Natale A. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122:109-18. PMID 20606120.</li>
<li>Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Della Russo A, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121:2550-6. Epub 2010 Jun 1. PMID: 20516376.</li>
<li>Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, Gallinghouse GJ, Themistoclakis S, Rossillo A, Lakkireddy D, Reddy M, Hao S, Hongo R, Beheiry S, Zagrodzky J, Rong B, Mohanty S, Elayi CS, Forleo G, Pelargonio G, Narducci ML, Dello Russo A, Casella M, Fassini G, Tondo C, Schweikert RA, Natale A. Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management: Results From the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) Randomized Trial. Circulation. 2014 ;129:2638-44.</li>
<li>Di Biase L, Santangeli P, Burkhardt D, Bai R, Mohanty P, Carbucicchio C, Dello Russo A, Casella M, Mohanty S, Pump A, et al. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2012; 60:132-141.</li>
<li>Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, Horton R, Sanchez JE, Bai R, Mohanty S, Pump A, Mauricio Cereceda Brantes, Gallinghouse GJ, Burkhardt JD, Federico Cesarani, Scaglione M, Natale A, Gaita F. Does the left atrial appendage morphology correlate with the risk of stroke in patients with AF? Result from a multicenter study. J Am Coll Cardiol. 2012;60:531-8.</li>
</ol>

EMR ID

5640

Biography

<p>Luigi Di Biase, MD, PhD, FACC, FHRS, is Section Head of Electrophysiology and Director of Arrhythmia Services at Montefiore as well as Professor of Medicine (Cardiology) at our&nbsp;<a href="http://www.einstein.yu.edu/faculty/13629/luigi-di-biase/&quot; target="_blank" rel="noopener noreferrer">Albert Einstein College of Medicine</a>.</p><p>Dr. Di Biase attended University of Bari in Bari, Italy, graduating&nbsp;from its medical school in 2000 and Cardiology residency program in 2004. In 2006, he completed a second-level master&rsquo;s degree in Electrophysiology and Pacing at the University of Insubria, in Varese, Italy.</p><p>In 2007, Dr. Di Biase received a grant from the Italian National Society of Cardiology to pursue a research fellowship at the Miller Family Heart &amp; Vascular Institute at the Cleveland Clinic. Dr. Di Biase completed the PhD program in cardiovascular physiopathology at the University of Foggia, Italy, in 2010.</p><p>Dr. Di Biase's research focuses on cardiology and electrophysiology, with an emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. His research focuses on heart failure, particularly in cases treated with cardiac resynchronization therapy devices.</p><p>Dr. Di Biase is the author of more than 450 publications in indexed journals, roughly 500 abstracts, and 16 electrophysiology book chapters. He has presented as an invited speaker at numerous national and international conferences and serves as Associate Editor for Pacing and Clinical Electrophysiology (PACE) as well as&nbsp;the Journal of Interventional Cardiac Electrophysiology (JICE). He is the Editorial Team Lead for the American College of Cardiology in the field of Electrophysiology. He co-authored the 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation, which is globally referenced for best-practices in cardiac ablation.</p><p>Dr. Di Biase is the highest published Electrophysiology faculty member and is also one of the world&rsquo;s most published physicians on the topic of cardiac electrophysiology and atrial fibrillation.<br /><br /> Dr. Di Biase is a member of the Italian Federation of Cardiology and Electrophysiology (FIC- AIAC), the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA), the American College of Cardiology (ACC), and the American Heart Association (AHA). He is a fellow of the Heart Rhythm Society (FHRS) and the American College of Cardiology (FACC), and is an honorary member of the Korean Society of Cardiology.</p>

Is Open Scheduling

On

Jooyoung (Julia) Shin

https://assets.montefioreeinstein.org/profiles/images/physphoto/Shin_Jooyoung_MD_420x504.jpg

First Name

Jooyoung (Julia)

Last Name

Shin

NPI

1821037961

Faculty ID

10716

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p align="left" style=" word-break: normal; text-align: left;"><span style=" color: black; font-size: 12.0pt; font-family: 'Times New Roman';">Clinical cardiology, specifically end-stage congestive heart failure, mechanical circulatory support, and cardiac transplantation.&#160;&#160;</span></p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Shin's clinical focus is on caring for patients with heart failure, particularly providing expertise in advanced heart failure, heart transplantation, and mechanical circulatory support.

Research Focus

Heart failure treatment is the primary focus of Dr. Shin&rsquo;s research. She is the site principal investigator for the effectiveness of omecamtiv mecarbil/AMG 423 to treat chronic heart failure with reduced ejection fraction (GALACTIC-HF) and multiple cardiac sensors for the management of heart failure (MANAGE-HF) trials.

Elsevier Profile

EMR ID

4843

Biography

<p>Jooyoung Julia Shin, MD, is Fellowship Director, Advanced Heart Failure and Transplant Cardiology Fellowship Program and Associate Professor, Medicine at Montefiore Einstein. Dr. Shin&rsquo;s clinical focus centers on heart failure, cardiac transplantation and mechanical circulatory support.</p><p>After obtaining her Bachelor of Science from the University of Michigan in 1994, Dr. Shin earned her Doctor of Medicine at George Washington University in 1999. She completed an internship and residency in internal medicine at the University of Maryland in 2002 before completing a cardiovascular disease fellowship at Emory University in 2005. Following this, Dr. Shin remained at Emory to complete an additional fellowship in advanced heart failure and transplant cardiology in 2006.</p><p>Dr. Shin&rsquo;s research focuses on fellow education. She has been principal investigator and co-principal investigator on several funded research projects, and she has presented at invited lectures nationwide. Her work has also been published in numerous peer-reviewed journals, and she has been a reviewer for scientific publications, including the <em>Mayo Clinic Proceedings</em>, the <em>American Journal of Cardiology</em> and <em>Pacing and Clinical Electrophysiology</em>, among others.</p><p>Dr. Shin is board certified by the American Board of Internal Medicine in Cardiovascular Disease, Internal Medicine and Advanced Heart Failure and Transplant Cardiology. She is a member of the American College of Cardiology and the International Society for Heart and Lung Transplantation.</p>

Is Open Scheduling

Off

Omar Saeed

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/42a61730-f4e6-11ed-b165-5b052597da41.jpg

First Name

Omar

Last Name

Saeed

NPI

1104003292

Faculty ID

14870

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Heart Failure</p>
<p>Cardiac Transplantation</p>
<p>Mechanical Circulatory Support</p>
<p>Hemolysis</p>
<p>&nbsp;</p>
<p><strong>Education and Training</strong></p>
<p>College: University of California, Berkeley</p>
<p>Medical School: New York Medical College</p>
<p>Residency: Emory University Hospital</p>
<p>Fellowships: Emory University Hospital, Montefiore Medical Center/Albert Einstein College of Medicine</p>
<p>&nbsp;</p>
<p><strong>Grant Support</strong></p>
<p>Hemolysis and Platelet Activation during Continuous Flow Mechanical Circulatory Support (NIH/NHLBI K23HL145140, PI: Saeed)</p>
<p>Jan 2019-Dec 2023</p>
<p>&nbsp;</p>
<p>&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Saeed's clinical focus is on heart failure, heart transplantation and mechanical circulatory support.

Research Focus

Dr. Saeed&rsquo;s research focuses on the mechanisms of hematological and neurological adverse events during mechanical circulatory support.&nbsp;

Elsevier Profile

Selected Publications

<p align="LEFT">1. <strong>Saeed O, </strong>Jakobleff WA, Forest SJ, Chinnadurai T, Mellas N, Rangasamy S, Xia Y, Madan S, Acharya P, Algodi M, Patel SR, Shin J, Vukelic S, Sims DS, Reyes Gil M, Billett HH, Kizer JR, Goldstein DJ, Jorde UP. Hemolysis and Non Hemorrhagic Stroke during Venoarterial Extracorporeal Membrane Oxygenation. The Annals of Thoracic Surgery, 2019.</p>
<p align="LEFT">2. Acharya P, Jakobleff WA, Forest SJ, Chinnaduria T, Mellas N, Patel SR, Kizer JR, Billett HH, Goldstein DJ, Jorde UP, <strong>Saeed O</strong>. Fibrinogen Albumin Ratio and Ischemic Stroke during Venoarterial Extracorporeal Membrane Oxygenation. ASAIO J. 2019.</p>
<p align="LEFT">3. Jorde UP, Shah A, Sims D, Madan S, Siddiqi N, Luke A,<strong> Saeed O</strong>, Patel SR, Murthy S, Shin J, Oviedo J, Watts S, Jakobleff WA, Forest SJ, Vukelic S, Belov D, Puius Y, Minamoto G, Muggia V, Carlese A, Leung S, Rahmaniam M, Leff J, Goldstein D. Continuous-Flow Left Ventricular Asssit Device Survival Improves with Multidisciplinary Approah. The Annals of Thoracic Surgery, 2019.</p>
<p align="LEFT">4. <strong>Saeed O</strong>, Jorde U. Impact and Measurement of Blood Pressure during Continuous Flow Left Ventricular Assist Device Support: The Pressure is On! <em>ASAIO J.</em> 2019.</p>
<p align="LEFT">5. Madan S, Patel SR, <strong>Saeed O</strong>, Sims DB, Shin JJ, Goldstein DJ, Jorde&nbsp;UP. Outcomes of heart transplantation in patients with human immunodeficiency virus. Am J Transplant. 2019</p>
<p align="LEFT">6. <strong>Saeed O,</strong> Patel SR, Jorde UP.&nbsp;Bleeding and Angiogenesis during Continuous Flow Left Ventricular Assist Device (CF LVAD) support - Enter the Von Willebrand Matrix. <em>Circulation Heart Failure</em>. 2018.</p>
<p align="LEFT">7. Farooqi KM, Cooper C, Chelliah A, <strong>Saeed</strong> <strong>O</strong>, Chai PJ, Jambawalikar SR, Lipson H, Bacha EA, Einstein AJ, Jorde UP.&nbsp; 3D Printing and Heart failure: The Present and the Future. <em><span class="jrnl" title="JACC. Heart failure">JACC Heart Fail</span></em>. 2018 Dec 10.</p>
<p align="LEFT">8. Patel SR, Madan S, <strong>Saeed O,</strong> Sims DB, Shin JJ, Nucci C, Borukhov E, Goldstein DY, Jakobleff W, Forest S, Vukelic S, Murthy S, Reinus J, Puius Y, Goldstein DJ, Jorde UP. Cardiac transplantation from non-viremic hepatitis C donors. <em>J Heart Lung Transplant</em>. 2018.</p>
<p align="LEFT">9. Vukelic S, Vlismas P, Patel SR, Xue X, Shitole S, <strong>Saeed O</strong>, Sims DS, Chinnadurai T, Shin J, Forset S, Goldstein DJ, Jorde UP. Digoxin is Associated with Decreased Incidence of Angiodysplasia-related Gastrointestinal Bleeding in&nbsp;Patients with Continuous-Flow Left Ventricular Assist Devices. <em>Circulation Heart Failure</em>. 2018.</p>
<p align="LEFT">10. <strong>Saeed O</strong>, Rangasamy S, Reyes Gil M, Goldstein DJ, Billett HH, Jorde UP, Patel SR.&nbsp; Speed Reduction Does Not Restore High Molecular Weight Multimers of von Willebrand Factor during HeartMate II Support: An In-Vivo Study. <em>ASAIO J</em>. Sep-Oct 2018.</p>
<p align="LEFT">11. Rangasamy S, Madan S, <strong>Saeed O</strong>, Goldstein DJ, Jorde UP, Negassa A, Patel SR. Noninvasive Measures of Pulsatility and Blood Pressure During Continuous-Flow Left Ventricular Assist Device. <span class="jrnl" title="ASAIO journal (American Society for Artificial Internal Organs : 1992)"><em>ASAIO J</em></span>. 2018</p>
<p align="LEFT">12. <strong>Saeed O</strong>, Rangasamy S, Selevany I, MadanS, Fertel J, Eisenberg R, Aljoudi M, Patel SR, Shin JJ, Sims DB, Reyes Gil M, Goldstein DJ, Slepian MJ, Billett HH, Jorde UP.&nbsp;Sildenafil is Associated with Reduced Device Thrombosis and Ischemic Stroke Despite Low Level Hemolysis on Heart Mate II support. <em>Circulation Heart Failure</em>. 2017.</p>
<p align="LEFT">13. Patel SR,&nbsp;<strong>Saeed</strong>&nbsp;<strong>O</strong>, Naftel D, Myers S, Kirklin J,&nbsp;Jorde&nbsp;UP, Goldstein DJ. Outcomes of Restrictive and Hypertrophic cardiomyopathies after LVAD: as INTERMACS Analysis.&nbsp;<em><span class="jrnl" title="Journal of cardiac failure">J Card Fail</span></em>. 2017 Sep 29. pii: S1071-9164(17)31220-4.</p>
<p>14. Madan S, <strong>Saeed</strong> <strong>O</strong>, Vlismas P, Katsa I, Patel SR, Shin JJ, Jakobleff WA, Goldstein DJ, Sims DB,Jorde UP. Outcomes After Transplantation of&nbsp;Donor&nbsp;Hearts With Improving Left&nbsp;Ventricular Systolic&nbsp;Dysfunction. <span class="jrnl" title="Journal of the American College of Cardiology"><em>J Am Coll Cardiol</em></span>. 2017 Sep 5;70(10):1248-1258.&nbsp;</p>
<p>15. Madan S, Patel SR, Vlismas P, <strong>Saeed</strong> <strong>O</strong>, Murthy S, Forest S, Jakobleff W, Sims D, Lamour JM, Hsu DT, Shin J, Goldstein D, Jorde UP. Outcomes of Early Adolescent Donor Hearts in Adult Transplant Recipients. <span class="jrnl" title="JACC. Heart failure"><em>JACC Heart Fail</em></span>. 2017. S2213-1779(17)30320-7.</p>
<p>16. Patel SR, Oh KT, Ogriki T, Sims D, Shin JJ, Madan S, <strong>Saeed O</strong>, Goldstein DJ, Jorde UP.&nbsp; Cessation of Continuous Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding After Heart Transplantation. <em><span class="jrnl" title="ASAIO journal (American Society for Artificial Internal Organs : 1992)">ASAIO J</span></em>. 2017.</p>
<p>17. Madan S, Sims D, <strong>Saeed O</strong>, Patel SR, Shin JJ, Jorde UP. Association of centre volume and in-hospital mortality in heart failure hospitalisations. <em><span class="jrnl" title="Postgraduate medical journal">Postgrad Med J</span></em>. 2017.</p>
<p>18. <strong>Saeed O.</strong>, Jorde U. Advances in Continuous Flow Left Ventricular Assist Device Support for End Stage Heart Failure - A Therapy in Evolution.&nbsp; <em>Cardiology in Review </em>2016.</p>
<p>19. Jermyn R., Alam A., Kvasic J., <strong>Saeed O</strong>., Jorde U. Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program. <em>Clinical Cardiology</em>. 2016 Nov.</p>
<p>20. Patel S.R., Madan S., <strong>Saeed O.,</strong> Algodi M., Luke A., Gibber M., Goldstein D.J., Jorde U.P. Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous Flow Left Ventricular Assist Devices. <em><span class="jrnl" title="JACC. Heart failure">JACC Heart Failure</span></em>. 2016 Sep 29. pii: S2213-1779(16)30444-9.</p>
<p>21. Madan S., <strong>Saeed O.,</strong> Shin J., Sims D., Goldstein D., Pina I., Jorde U., Patel S. Donor Troponin&nbsp;and Survival after Cardiac Transplantation &ndash; An Analysis of the UNOS Registry. <em>Circ Heart Failure. </em>2016; Jun;9(6).</p>
<p>22. Levin A., <strong>Saeed O.,</strong> Willey, J., Levin C., Fried J., Patel S., Sims D., Nguyen J., Shin J., Topkara V., Colombo P., Goldstein DJ., Yoshifumi N., Takayama H., Uriel N, Jorde U. &nbsp;Watchful Waiting in CF-LVAD Patients with&nbsp;Ongoing Hemolysis is Associated with an Increased Risk for Cerebrovascular Accidents and Death.&nbsp;&nbsp;<em>Circ Heart Failure. </em>2016 May;9(5).</p>
<p>23. Farooqi K., <strong>Saeed O</strong>., Zaidi A., Sanz J., Nielsen J., Hsu D., Jorde U. 3D Printing to Guide Ventricular Assist Device placement in Adults with Congenital Heart Disease and Heart Failure. <em>JACC Heart Failure</em>. 2016;4: 301-11.</p>
<p>24. <strong>Saeed O.</strong>, Shah A., Kargoli F., Madan S., Levin AP., Patel SR., Jermyn R., Guerrero C., Nguyen J., Sims DB., Shin J., Goldstein D., Jorde U. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support. <em>Circ Heart Failure.</em> 2016; 9 (1):e002296.</p>
<p class="Body1">25.<strong> Saeed O</strong>, Jermyn R, Kargoli F., Madan S., Mannem S, Cecilia N, Hassan S., Farooqui S, Bloom&nbsp;M, Mclarty A,^&nbsp;Zolty R, Shin J, D&rsquo;Alessandro D, Goldstein D, Patel&nbsp;S.&nbsp; Blood pressure and adverse events during continuous flow left ventricular assist device support.<em>&nbsp; Circ Heart Failure. </em>2015; 8(3):551-6.</p>
<p class="Body1">26. Habib A, Polavarapu R., Karmali V., Guo L., Van Dam R., Cheng A,. Akahori H., <strong>Saeed O.,</strong> Mastaka N., Pachura K., Hong C., Shin E., Kolodgie F., Virmani, Finn AV. The Hepcidin-Ferroportin1 Axis Controls Toll-Like Receptor 4-Dependent Macrophage Inflammatory Responses in Human Atherosclerotic Plaques. <em>Atherosclerosis</em>. 2015; 241(2) 692-700.</p>
<p>27. <strong>Saeed O.,</strong> Gupta A., Gross J, Palma E.&nbsp; Rate of Cardiovascular Implanted Electronic Device (CIED) re-extraction after recurrent infection. <em>Pacing and Cardiac Electrophysiology. </em>2014<em>; </em>37(8): 963-8.</p>
<p>28. Galvao M., <strong>Saeed O</strong>., Immekus J., Goldstein D., Maybaum S. An International Survey to assess Referral Thresholds for Left Ventricular Assist Device Destination Therapy in Non-Inotrope Dependent patients: Results of the Consensus DT study.&nbsp; <em>Journal of Cardiac Failure. </em>2014; 20(7):492-7.</p>
<p>29. <strong>Saeed O.,</strong> Maybaum S., D&rsquo;Alessandro D., Goldstein D. Patel SR.&nbsp; Aortic Valve Opening and Thrombotic Events with Continuous Flow Left Ventricular Assist Devices. <em>J Heart Lung Transplant</em>. 2014; 33(1):109-12.</p>
<p class="Body1">30. Patel SR., <strong>Saeed O.</strong>, Murthy S., Bhatia V., Shin JJ., Wang D., Negassa A., Pullman J., Goldstein D., Maybaum S. Combining Neurohormonal Blockade with Continuous Flow Left Ventricular Assist Device (CF-LVAD) Support for Myocardial Recovery - A Single Arm Prospective Study<em>. J Heart Lung Transplant.</em> 2013; 32(3): 305-12.</p>
<p>31. <strong>Saeed O.</strong>, Bhatia V., Formica P., Browne A., Aldrich TK., Shin JJ., Maybaum S.&nbsp; Improved exercise performance and skeletal muscle strength after simulated altitude exposure: A novel approach for patients with chronic heart failure. <em>J Card Fail</em>. 2012; 18(5):387-91.</p>
<p>32. Finn AV, <strong>Saeed O</strong>, Virmani R. Macrophage subsets in human atherosclerosis. <em>Circulation Research. </em>2012; 110(9):e64.</p>
<p>33.<strong> Saeed O.</strong>, Otsuka F., Polavarapu R., Karmali V., Weiss D., Davis T., Rostad B.,&nbsp; Pachura K., Adams L., Elliot J., Taylor RW., Narula J., Hong C., Kolodgie F., Virmani R., Finn AV. Pharmacologic suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. <em>Arterioscler Thromb Vasc Biol</em><em>.</em> 2012; 32: 299-307.</p>
<p>34. Finn AV., Nakano M., Polavarapu R., Karmali V., <strong>Saeed O.</strong>,Zhao X., Yazdani S., Davis T., Habib A., Narula J., Kolodgie F, Virmani R. Hemoglobin directs macrophage differentiation and determines lipid uptake human atherosclerotic plaques. <em>J Am Coll Cardiol</em>. 2012; 59(2): 166-177.</p>
<p>35. Wei C., Li L., Torben B., <strong>Saeed O.</strong>, Thabet S., Jansen T., Dikalov S., Weyand C.,Goronzy J., Harrison DG. The role of increased GTP cyclohydrolase-1 expression and tetrahydrobiopterin levels upon T cell activation. <em>J Biol Chem. </em>2011; 286(16): 13846-51.&nbsp;</p>
<p>36.<strong> Saeed O</strong>., Yaghmaie F., Garan SA., Gouw A., Voelker M., Freitag W., Sternberg H., Timiras PS. Insulin like Growth Factor -1 immunoreactive cells are selectively maintained in the paraventricular hypothalamus of calorically restricted mice <em>Intl. J.</em> <em>Dev. Neuroscience. </em>2007; 25(1):23-8.</p>
<p>37. Yaghmaie F., <strong>Saeed O.</strong>,Garan S.A., Gouw A., Voelker M., Freitag W., Sternberg H.,&nbsp; Timiras PS. Age dependent loss of Insulin like Growth Factor -1 immunoreactive cells in the supraoptic hypothalamus is reduced in calorically restricted mice. <em>Intl. J. Dev. Neuroscience. </em>2006; 24(7):431-6.</p>

EMR ID

57127

Biography

<p>Omar Saeed, MD, is an Attending Cardiologist at Montefiore and Assistant Professor of Medicine at our Albert Einstein College of Medicine. His clinical focus is on heart failure, heart transplantation and mechanical circulatory support.</p><p>After receiving his Bachelor of Arts in molecular and cellular biology from the University of California, Berkeley in 2003, Dr. Saeed attended New York Medical College, earning his Doctor of Medicine in 2007. He began his postdoctoral training at Emory University Hospital, completing a residency in internal medicine in 2010 and a fellowship in cardiovascular disease in 2011. He then transferred to Albert Einstein College of Medicine. Here he completed a research fellowship in heart failure, transplant and mechanical circulatory support in 2012, a cardiovascular disease fellowship in 2014 and a fourth-year clinical fellowship in advanced heart failure and transplant in 2015.</p><p>Dr. Saeed&rsquo;s research focuses on the mechanisms of hematological and neurological adverse events during mechanical circulatory support. He has published as primary author or as co-author over 50 peer-reviewed manuscripts, and he has presented regionally, nationally and internationally. He also has been an invited manuscript reviewer for many journals, including <em>Haemostasis and Thrombosis, </em>the <em>Journal of Lung and Heart Transplantation</em> and the <em>Journal of Human Immunology</em>.</p><p>Dr. Saeed has received the Martin Cohen award for excellence in cardiovascular fellowship training, the Edmund Sonnenblick award for excellence in heart failure research and the NIH K23 career development award supporting his commitment to patient-oriented research. He is board certified and is a member of several professional organizations, including the American College of Cardiology, the American Society of Echocardiography and the International Society of Heart and Lung Transplant.</p>

Is Open Scheduling

Off

Judah N. Rauch

https://assets.montefioreeinstein.org/profiles/images/physphoto/Rauch_Judah_MD_420x504.jpg

First Name

Judah

Last Name

Rauch

NPI

1104140151

Faculty ID

16109

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Rauch's clinical focus is on the treatment of patients with coronary artery disease. He has a particular interest in the care of patients with acute coronary syndromes, cardiogenic shock and complex coronary disease.</span>

Research Focus

<p><span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Rauch&rsquo;s research builds on his clinical interests and is focused on bringing large, multi-site clinical trials to Montefiore, affording patients the opportunity to benefit from new and innovative therapies.</span></p>

Elsevier Profile

EMR ID

2509

Biography

<p>Judah Nathaniel Rauch, MD, is an Interventional Cardiologist at Montefiore and Assistant Professor of Clinical Medicine at our Albert Einstein College of Medicine. His clinical focus is on the treatment of patients with coronary artery disease. He has a particular interest in the care of patients with acute coronary syndromes, cardiogenic shock and complex coronary disease.</p><p>Dr. Rauch earned his Bachelor of Arts at Yeshiva University in 2006, followed by his Doctor of Medicine at New York University School of Medicine in 2010. He began his postdoctoral training at New York&rsquo;s Mount Sinai Hospital, completing a residency in internal medicine in 2013, serving as chief resident in 2014 and completing a fellowship in cardiovascular disease in 2017. In 2018, he completed an interventional cardiology fellowship at Montefiore Medical Center; he received his Master of Business Administration from the University of Massachusetts in the same year.</p><p>Dr. Rauch&rsquo;s research builds on his clinical interests and is focused on bringing large, multi-site clinical trials to Montefiore, affording patients the opportunity to benefit from new and innovative therapies.</p><p>Dr. Rauch is board certified in interventional cardiology, cardiovascular disease and internal medicine by the American Board of Internal Medicine.</p>

Is Open Scheduling

On

Snehal R. Patel

https://assets.montefioreeinstein.org/profiles/images/physphoto/Patel_Snehal_MD_420x504.jpg

First Name

Snehal

Last Name

Patel

NPI

1770740714

Faculty ID

13032

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Clinical areas of expertise include heart failure, cardiac transplantation, mechanical circulatory support.</p>

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5347

Is Open Scheduling

Off

E. Scott Monrad

https://assets.montefioreeinstein.org/profiles/images/physphoto/Monrad_Scott_MD_420x504.jpg

First Name

E.

Last Name

Monrad

NPI

1942399266

Faculty ID

156

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Monrads' clinical focus is on interventional cardiology, hemodynamic assessment of valvular heart disease and hemodynamic assessment of congestive heart failure. He also has an interest in preventive cardiology in outpatients.

Research Focus

Dr. Monrad&rsquo;s research focuses on improving clinical outcomes in patients with coronary artery disease.

Elsevier Profile

EMR ID

3410

Biography

<p>E. Scott Monrad, MD, CM, is Training Program Director, Cardiovascular Diseases; Director of Cardiovascular Quality; and Vice Chief of Cardiology, Patient Safety and Quality at Montefiore. He is also Professor of Clinical Medicine at our Albert Einstein College of Medicine. His clinical focus is on interventional cardiology, hemodynamic assessment of valvular heart disease and hemodynamic assessment of congestive heart failure. He also has an interest in preventive cardiology in outpatients.</p><p>After receiving his Bachelor of Arts from Harvard University in 1975, Dr. Monrad went on to receive his Doctor of Medicine and Master of Surgery in 1979 from McGill University Medical School in Montreal, Quebec. He attended New England Medical Center Hospital for the start of his postdoctoral training, completing an internship in medicine in 1980, and a residency in 1982. From 1982 to 1985, he was a fellow in the cardiovascular division at the Harvard Beth Israel Hospital in Boston, and from 1985 to 1986, he was a research fellow with the cardiology department at Medizinische Poliklinik, Universitaetsspital in Zurich, Switzerland.</p><p>Dr. Monrad&rsquo;s research focuses on improving clinical outcomes in patients with coronary artery disease. His research findings have been published in many reviewed journals and abstracts. He has also contributed to many books.</p><p>Dr. Monrad has been included in Castle Connolly Top Doctors. He is board certified and is a member of several professional associations.</p>

Is Open Scheduling

Off

Mark A. Menegus

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f2e6b3e0-c947-11ed-ac75-a11bc3df2fd1.jpg

First Name

Mark

Last Name

Menegus

NPI

1174613079

Faculty ID

6501

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<span style="background-color:#ffffff;"><span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, Courier New, monospace;"><span style="font-size:16px;">Dr. Menegus's clinical&nbsp;focus has been interventional and clinical cardiology, interventional management of acute myocardial infarction, acute coronary syndromes, outpatient consultative cardiology and training general and interventional cardiology fellows.</span></span></span>

Research Focus

<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Menegus has been the Principal Investigator for many research projects, including the NIH-sponsored Myocardial Infarction and Transfusion trial, the SHOCK trial, and the PHRI-sponsored COMPLETE trial.</span>

Elsevier Profile

EMR ID

3401

Biography

<p>Mark A. Menegus, MD, FACC, FSCAI, is Director of Cardiac Catheterization Laboratory at Montefiore&rsquo;s Einstein campus and Professor of Medicine at Albert Einstein College of Medicine. Since joining Montefiore, his focus has been interventional and clinical cardiology, interventional management of acute myocardial infarction, acute coronary syndromes, outpatient consultative cardiology and training general and interventional cardiology fellows.</p><p>In 1977, Dr. Menegus received his Bachelor of Arts in Biological Science/Physiology from Rutgers University. He then attended Rutgers Medical School, where he received his Doctor of Medicine in 1981. From 1981 to 1987, Dr. Menegus completed an internship and residency in internal medicine and a fellowship in cardiology at Montefiore, also serving as an Assistant Firm Leader in the Deparment of Medicine.</p><p>Dr. Menegus has been the Principal Investigator for many research projects, including the NIH-sponsored Myocardial Infarction and Transfusion trial, the SHOCK trial, and the PHRI-sponsored COMPLETE trial. His work has been published in peer-reviewed journals, books and abstracts and has been presented nationally.</p><p>He is board certified by the American Board of Internal Medicine and is a member of numerous professional societies, including the American College of Cardiology, the Society for Cardiac Angiography and Intervention and the American Heart Association. Dr. Menegus has been listed in Castle Connolly Medical as a New York Metro Area Top Doctor from 2001 to 2019. </p>

Is Open Scheduling

Off

Mohamed Azeem Latib

https://assets.montefioreeinstein.org/profiles/images/physphoto/Latib_Azeem_MD_420x540.jpg

First Name

Mohamed Azeem

Last Name

Latib

NPI

1285108910

Faculty ID

16484

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Latib is a world-leading expert in interventional cardiology, with a clinical focus on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions.&nbsp;

Research Focus

Following from his clinical interests, Dr. Latib&rsquo;s research centers on transcatheter aortic, mitral and tricuspid interventions with a focus on device innovation. In addition, he performs research on drug-coated balloons, drug-eluting stents and challenging lesion subsets.

Elsevier Profile

EMR ID

102954

Biography

<p>Azeem Latib, MB BCh, is Medical Director of Structural Heart Interventions at Montefiore. Dr. Latib is a world-leading expert in interventional cardiology, with a clinical focus on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions. He has extensive clinical experience in TAVR and MitraClip, as well as expertise in novel and new devices to treat mitral and tricuspid valve disease minimally invasively without open-heart surgery.</p><p>In 1995, Dr. Latib received his Bachelor of Medicine at the University of Witwatersrand in Johannesburg, South Africa. He completed a fellowship with the College of Physicians of South Africa in 2002, followed by a certificate in cardiology from the same institution in 2005. In 2008 he completed a master&rsquo;s in interventional cardiology at San Raffaele Scientific Institute and University Vita Salute in Milan, Italy. In 2018, he attended the University of Zurich to earn a certificate of advanced studies in aortic structural interventions.</p><p>Following from his clinical interests, Dr. Latib&rsquo;s research centers on transcatheter aortic, mitral and tricuspid interventions with a focus on device innovation. In addition, he performs research on drug-coated balloons, drug-eluting stents and challenging lesion subsets. His findings have been published widely, with more than 550 peer-reviewed publications. Dr. Latib serves on the editorial board for many journals, including <em>Cardiac Interventions Today</em>, the <em>Journal of the American College of Cardiology,</em> <em>Cardiovascular Interventions</em> and <em>Cardiovascular Revascularization Medicine</em>. He is a reviewer for many more journals and serves on the faculty of several international conferences.</p><p>Dr. Latib is a member of several professional organizations, including the American College of Cardiology and the European Society of Cardiology.</p>

Is Open Scheduling

Off

Nils A. Guttenplan

https://assets.montefioreeinstein.org/profiles/images/physphoto/Guttenplan_Nils_MD_420x504.jpg

First Name

Nils

Last Name

Guttenplan

NPI

1952399610

Faculty ID

17478

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Dr. Guttenplan is committed to improving the patient's quality of life and prognosis across the spectrum of heart rhythm disorders. All contemporary approaches including pacemakers, defibrillators, catheter ablations, and left atrial appendage occlusion devices are drawn upon to achieve this aim.</p>

Research Focus

<p>Dr. Guttenplan is the principle investigator at Montefiore in an outcomes study of a left ventricular quadrapolar pacing lead. During the study he as adapted the use of an interventional snare technique. This approach has allowed for successful left ventricular lead placement, that would not have been possible with the conventional approach. Dr. Guttenplan is also a co-investigator in the division's ablation studies.</p>

Elsevier Profile

EMR ID

5134

Biography

<p>Nils A. Guttenplan, MD, is an Attending Physician in the Cardiology Department at Montefiore. His clinical focus is improving the patient's quality of life and prognosis across the spectrum of heart rhythm disorders. He has an interest in all contemporary approaches to achieve this aim, including pacemakers, defibrillators, catheter ablations, and left atrial appendage occlusion devices. Dr. Guttenplan joined the Montefiore team in 2018.</p><p>Dr. Guttenplan attended New York Medical College&nbsp;where he received his Doctor of Medicine. In 2004, Dr. Guttenplan completed a residency in Internal Medicine at St. Vincent?s Medical Center. He completed a fellowship in Cardiovascular Disease at our Albert Einstein College of Medicine, followed by a fellowship in Clinical Cardiac Electrophysiology at New York University.</p><p>Dr. Guttenplan is the Principal Investigator in a study on left ventricular quadripolar pacing lead. During the study, he has developed the use of an interventional snare technique that has allowed for successful left ventricular lead placement that would not have been possible with the conventional approach. Dr. Guttenplan is also a co-Investigator in the division's ablation studies. His work has been published in numerous peer-reviewed journals.</p>

Is Open Scheduling

Off

Jay N. Gross

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/97818220-d2b6-11eb-9e1e-a35c32ad7e94.jpg

First Name

Jay

Last Name

Gross

NPI

1750470092

Faculty ID

2274

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Dr. Gross specializes in complex electrophysiology (EP) management problems as well as issues related to implantation and management of all types of implantable electrical devices, with a focus on lead extraction.</p>

Research Focus

<p>Dr. Gross has been a principal site or co-investigator in many of the critical clinical trials that have established the utility and indications for pacemaker mode selection, rate modulated pacing, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy. Most recently, he has been involved in studies designed to define the role of temporary external defibrillator systems and the safety of implantable devices in the magnetic resonance imaging (MRI) setting. He has also been principal or co-author of dozens of scientific publications.</p>

Elsevier Profile

EMR ID

3641

Biography

<p>Jay N. Gross, MD, serves as an Attending Physician and Director of the Implantable Electrical Devices Service at Montefiore, as well as Professor of Medicine (Cardiology) at our <a href="http://www.einstein.yu.edu/faculty/2274/jay-gross/&quot; rel="noopener noreferrer" target="_blank">Albert Einstein College of Medicine</a>. His clinical focus is on complex electrophysiology (EP) management problems as well as issues related to implantation and management of all types of implantable electrical devices, with a focus on lead extraction.</p><p>After graduating from our Albert Einstein College of Medicine, and completing his residency at Montefiore in Internal Medicine, Dr. Gross continued on to complete a cardiology fellowship at Montefiore. <br /><br />Dr. Gross has been a principal site or co-investigator in many of the critical clinical trials that have established the utility and indications for pacemaker mode selection, rate-modulated pacing, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy. Most recently, he has been involved in studies designed to define the role of temporary external defibrillator systems and the safety of implantable devices in the magnetic resonance imaging (MRI) setting. He has also been principal or co-author of dozens of scientific publications.</p><p>Recent clinical highlights for Dr. Gross include: the first reported cases of implantation of subcutaneous ICDs in heart transplant patients, simultaneous lead extraction and debulking of large vegetations in patients with endocarditis, concomitant lead extraction and implantation of leadless pacemakers, and care for of congenital heart patients who require both transvenously implanted devices and subcutaneous ICDs.</p><p>Dr. Gross is board certified in Internal Medicine, Cardiology, and Cardiovascular Electrophysiology as well as a Certified Cardiac Device Specialist (CCDS) by the International Board of Heart Rhythm Examiners. He is a Fellow of the American College of Cardiology and a member of the Heart Rhythm Society. Dr. Gross has served on the Writing Committee of the International Board of Heart Rhythm Board of Examiners for over two decades and now serves on its board of directors. He has been named to the Castle Connolly/NY Magazine List of Best EP Doctors in New York for the past two years.</p>

Is Open Scheduling

Off